The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of tumor site on bevacizumab (BEV) efficacy in metastatic colorectal cancer (mCRC).
Hui-Li Wong
Research Funding - Roche Australia
Kathryn Maree Field
Research Funding - Roche Australia
Anna Lomax
Research Funding - Roche Australia
Mark Tacey
Research Funding - Roche Australia
Jeremy David Shapiro
Research Funding - Roche Australia
Joseph James McKendrick
Research Funding - Roche Australia
Allan Solomon Zimet
Research Funding - Roche Australia
Desmond Yip
Research Funding - Roche Australia
Louise M. Nott
Research Funding - Roche Australia
Ross Jennens
Research Funding - Roche Australia
Gary Edward Richardson
Research Funding - Roche Australia
Jeanne Tie
Research Funding - Roche Australia
Suzanne Kosmider
Research Funding - Roche Australia
Phillip Parente
Research Funding - Roche Australia
Lionel Lim
Research Funding - Roche Australia
Prasad Cooray
Research Funding - Roche Australia
Ben Tran
Research Funding - Roche Australia
Jayesh Desai
Research Funding - Roche Australia
Rachel Wong
Research Funding - Roche Australia
Peter Gibbs
Research Funding - Roche Australia